Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Colebatch

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Oncotarget|November 19, 2016
Novel metastatic models of esophageal adenocarcinoma derived from FLO-1 cells highlight the importance of E-cadherin in cancer metastasisDavid S Liu, Sanne J M Hoefnagel, Oliver M Fisher, et al.
Pathology|March 7, 2022
Pathologist initiated reflex BRAF mutation testing in metastatic melanoma: experience at a specialist melanoma treatment centreAlison J Potter, Andrew J Colebatch, Robert V Rawson, et al.
Scientific Reports|July 26, 2018
Multiplex immunohistochemistry accurately defines the immune context of metastatic melanomaH Halse, A J Colebatch, P Petrone, et al.
Nature Cancer|December 11, 2020
Molecular analysis of primary melanoma T cells identifies patients at risk for metastatic recurrenceWiebke Pruessmann, Julie Rytlewski, James Wilmott, et al.
Genome Medicine|May 26, 2026
Enhanced measures of neoantigenicity capture unique tumor-immune interactions across primary melanoma subtypesEva R Shteinman, Grace H Attrill, Nigel G Maher, et al.
Journal for Immunotherapy of Cancer|June 10, 2022
Higher proportions of CD39+ tumor-resident cytotoxic T cells predict recurrence-free survival in patients with stage III melanoma treated with adjuvant immunotherapyGrace Heloise Attrill, Carina N Owen, Tasnia Ahmed, et al.
The Journal of Pathology|April 4, 2017
Cousins not twins: intratumoural and intertumoural heterogeneity in syndromic neuroendocrine tumoursAidan Flynn, Trisha Dwight, Diana Benn, et al.
The Journal of Investigative Dermatology|February 18, 2019
Molecular Genomic Profiling of Melanocytic NeviAndrew J Colebatch, Peter Ferguson, Felicity Newell, et al.
Annals of Surgical Oncology|May 18, 2024
The Effect of Neoadjuvant Systemic Therapy on Surgical Outcomes After Lymph Node Dissections for Stage III Melanoma; An Australian CohortLisanne P Zijlker, Henry Chen, Andrew J Spillane, et al.
Cancer Immunology Research|September 12, 2020
Tumor Mutation Burden and Structural Chromosomal Aberrations Are Not Associated with T-cell Density or Patient Survival in Acral, Mucosal, and Cutaneous MelanomasJarem Edwards, Peter M Ferguson, Serigne N Lo, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Oncotarget|November 19, 2016
Novel metastatic models of esophageal adenocarcinoma derived from FLO-1 cells highlight the importance of E-cadherin in cancer metastasisDavid S Liu, Sanne J M Hoefnagel, Oliver M Fisher, et al.
Pathology|March 7, 2022
Pathologist initiated reflex BRAF mutation testing in metastatic melanoma: experience at a specialist melanoma treatment centreAlison J Potter, Andrew J Colebatch, Robert V Rawson, et al.
Scientific Reports|July 26, 2018
Multiplex immunohistochemistry accurately defines the immune context of metastatic melanomaH Halse, A J Colebatch, P Petrone, et al.
Nature Cancer|December 11, 2020
Molecular analysis of primary melanoma T cells identifies patients at risk for metastatic recurrenceWiebke Pruessmann, Julie Rytlewski, James Wilmott, et al.
Genome Medicine|May 26, 2026
Enhanced measures of neoantigenicity capture unique tumor-immune interactions across primary melanoma subtypesEva R Shteinman, Grace H Attrill, Nigel G Maher, et al.
Journal for Immunotherapy of Cancer|June 10, 2022
Higher proportions of CD39+ tumor-resident cytotoxic T cells predict recurrence-free survival in patients with stage III melanoma treated with adjuvant immunotherapyGrace Heloise Attrill, Carina N Owen, Tasnia Ahmed, et al.
The Journal of Pathology|April 4, 2017
Cousins not twins: intratumoural and intertumoural heterogeneity in syndromic neuroendocrine tumoursAidan Flynn, Trisha Dwight, Diana Benn, et al.
The Journal of Investigative Dermatology|February 18, 2019
Molecular Genomic Profiling of Melanocytic NeviAndrew J Colebatch, Peter Ferguson, Felicity Newell, et al.
Annals of Surgical Oncology|May 18, 2024
The Effect of Neoadjuvant Systemic Therapy on Surgical Outcomes After Lymph Node Dissections for Stage III Melanoma; An Australian CohortLisanne P Zijlker, Henry Chen, Andrew J Spillane, et al.
Cancer Immunology Research|September 12, 2020
Tumor Mutation Burden and Structural Chromosomal Aberrations Are Not Associated with T-cell Density or Patient Survival in Acral, Mucosal, and Cutaneous MelanomasJarem Edwards, Peter M Ferguson, Serigne N Lo, et al.
Pageof 6